-+ 0.00%
-+ 0.00%
-+ 0.00%

CAREDX ANNOUNCES NEW KOAR DATA LINKING ELEVATED ALLOSURE® KIDNEY TO NEARLY 3-FOLD HIGHER RISK OF ADVERSE GRAFT OUTCOMES IN PATIENTS WITH BORDERLINE REJECTION OR TCMR AT ASN KIDNEY WEEK 2026

Reuters·10/22/2026 11:05:00

Please log in to view news